JustPaste.it

Blood Transfusion Mastery Guide (Limited-Resource Settings)

🩸 Blood Transfusion Mastery Guide (Limited-Resource Settings)

From Safety to Survival: The Clinician’s Manual for Real-World Transfusion Practice

About This Guide

Prepared for Dr. Amir Fadhel — Specialist in Anesthesiology and Critical Care
In collaboration with Sophia (ChatGPT-4o) and continuing the legacy of the Mastery Series (ABG v2.0, Sputumology ICU, Dysrhythmia Essentials), this guide translates transfusion medicine into actionable, bedside-ready knowledge for resource-limited hospitals—where whole blood remains the backbone, PRBC and FFP supplies fluctuate, and clinical judgment often replaces laboratory immediacy.

It is structured for teaching, daily reference, and rapid decision-making in the OR, ICU, and obstetric theater, emphasizing physiology, safety, and ethics in scarcity.

Visual Plan: Compatibility wheels • Whole-blood composition charts • Rapid hemorrhage algorithms • Obstetric PAS flowcharts • DIC recognition matrices • TXA timelines • Dosing tables • Audit templates

Official Table of Contents

1. Foundations & Fast Orientation

1.1 What Transfusion Really Treats — O₂ Delivery, Coagulopathy & Volume
1.2 Whole Blood vs Components — Composition, Storage, Clinical Impact
1.3 Quick Physics of O₂ Delivery (DO₂ = CO × CaO₂) — Why Hb Matters Most
1.4 The Limited-Resource Mindset — Triage and Safety Thresholds
1.5 Bedside Card: Ten Rules That Prevent Fatal Errors
🖼️ Image: “At-a-Glance” OR/ICU Wall Poster

2. Compatibility & Testing — Minimal Delay, Maximum Safety

2.1 ABO/Rh Basics in 2 Minutes
2.2 Type & Screen vs Crossmatch — Timelines and Meaning
2.3 Emergency Release — When to Use O⁻ vs O⁺
2.4 Switching from O to Type-Specific Safely
2.5 Cut-Through Visuals: Compatibility Wheel + “Do Not Mix” Map

3. Components & Dosing You Actually Have

3.1 Whole Blood — When It Beats Component Therapy
3.2 PRBC — Expected Hb Rise, Storage Lesions, Scarcity Decisions
3.3 FFP — mL/kg Dosing and INR Targets Without Overload
3.4 Platelet Absence — Compensation with Whole Blood + FFP
3.5 Cryoprecipitate — Fibrinogen Thresholds & Exact Dosing Math
3.6 Adjuncts: Vitamin K, Calcium, DDAVP, rFVIIa — Where Each Fits
📊 Table: “What to Use When You Cannot Get Platelets”

4. Indications & Thresholds — Adult • Pediatric • Neonatal

4.1 Hemoglobin Triggers by Context (Bleed, Sepsis, Cardiac)
4.2 Coagulation Targets When Labs Lag (INR, Fibrinogen, Platelets)
4.3 NICU/PICU Volumes and Exchange Scenarios
🌀 Visual: Pediatric Dose Wheel (mL/kg Quick Calculator)

5. Massive Hemorrhage Protocol (MHP/MTP) in Low-Supply Hospitals

5.1 Activation Criteria Without Labs
5.2 Whole-Blood-Forward Strategy vs 1:1:1 When Platelets Absent
5.3 TXA Timing (<3 h Rule) and Repeat Logic; Aminocaproic Fallback
5.4 Lethal Triad (Hypothermia, Hypocalcemia, Acidosis) — Fix Cycle
5.5 Rapid Checklists: OR • ER • ICU (one-page each)
🔁 Flowchart: “Press Here” MHP Button Algorithm

6. Obstetric Hemorrhage — Beyond ‘PPH’: PAS, Rupture, Atony

6.1 4 Ts Framework (Atony • Trauma • Tissue • Thrombin)
6.2 Placenta Accreta Spectrum — Planning in Scarcity
6.3 Intra-op Playbook — Whole Blood + FFP Cycles and Cryo Timing
6.4 Uterotonics vs Transfusion Sequence • When Hysterectomy Saves Blood
6.5 PAS Algorithms — Rural to Tertiary Settings
🌿 Diagram: PAS Decision Tree

7. Disseminated Intravascular Coagulation (DIC)

7.1 Clinical Recognition Before Labs (Oozing Pattern, Swab Test)
7.2 Lab-Based Scoring When Available (ISTH, Fibrinogen < 1 g/L)
7.3 Replacement Strategy When Platelets Absent (WB + FFP)
7.4 DIC vs Dilutional vs Liver Failure — Parallel Correction Logic
🧩 Matrix: DIC Look-Alikes • Flowchart: OB vs Sepsis vs Trauma

8. Transfusion Reactions — See It, Stop It, Fix It

8.1 Acute Hemolysis, FNHTR, Allergic/Anaphylaxis — Immediate Steps
8.2 TRALI vs TACO — Bedside Differentiation and Action
8.3 Delayed Hemolysis, Sepsis, Iron Overload
📋 One-Pager: “Stop–Check–Support–Notify” Protocol
🔍 Diagram: TRALI vs TACO Side-by-Side

9. Special Populations & Ethics in Scarcity

9.1 Cardiac Disease • Elderly • Chronic Anemia in ICU
9.2 Liver Failure and Coagulopathy Without Platelets
9.3 Jehovah’s Witness Pathways • Consent Under Refusal
9.4 Peri-Anesthesia Caveats (Regional vs GA Under Coagulopathy)
9.5 Ethics & Triage: Prioritization When Every Unit Counts

10. Logistics, Stewardship & Quality Assurance

10.1 Inventory Triage — Who Gets O⁻ vs O⁺
10.2 Labeling and Zero-Mistake ID Checks
10.3 Cold-Chain Integrity and Transport in Hot Climates
10.4 Rational Use Audits and Behavior Change Forms
🗂️ Template: Maternal Transfusion Audit Sheet (Print-Ready)

11. Checklists, Tables & Calculators (Tear-Outs)

11.1 Dose and Volume Reference (adult/pediatric/neonatal)
11.2 Fibrinogen & Cryo Dose Quick Math
11.3 TXA / Aminocaproic Dosing Ladder
11.4 Reaction Management Box
11.5 Visual EBL Tools (Gravimetric + Visual Guide)
11.6 Massive Transfusion 3-Step Box: Warm → Calcium → TXA

12. Case-Based Mastery (Real-World Scenarios)

12.1 Twin Atony — No Platelets On Site → WB + FFP Rescue
12.2 Percreta in District OR — Planned Blood Path Saves Life
12.3 Polytrauma Unknown Type — Switch Timing to Type-Specific
12.4 Sepsis-DIC in ICU — Bleeding with Rising Lactate
12.5 Neonatal Exchange in Resource-Thin Nursery
📖 Each Case: Timeline • Decisions • Pitfalls • Red Flags • Debrief

13. Appendices & Printable Tools

13.1 One-Page MHP (adult/OB)
13.2 Rural DIC Algorithm
13.3 Compatibility Wheel (Laminated)
13.4 Audit & Incident Report Forms
13.5 Conversion Tables & Quick Math Charts

14. References

Core Texts: Morgan & Mikhail, Miller, Barash
Guidelines: AABB • WHO • NICE • RCOG • EAST

  • Curated Recent Papers with Direct Links (Shareable for Telegram/Teaching)

15. Final Words — Blood as a Promise

A reflection on clinical courage, precision, and mercy in scarcity — how disciplined transfusion practice, guided by physiology and empathy, becomes the ultimate form of healing when technology runs thin and judgment carries life itself.

1. Foundations & Fast Orientation

🧠 1.1 What Transfusion Really Treats — Oxygen Delivery, Coagulopathy & Volume

Before reaching for blood, always ask:
What am I treating — oxygen debt, coagulation failure, or volume loss?

Transfusion is not a treatment for anemia itself — it’s a rescue for oxygen delivery failure.

🔹 The Three Pillars:

  1. Oxygen-Carrying Capacity → provided mainly by hemoglobin
  2. Coagulation Factor Support → from FFP / cryoprecipitate / platelets (or whole blood)
  3. Volume Restoration → essential for circulatory stability but never the goal alone

In low-resource hospitals, whole blood often serves all three purposes simultaneously — but the danger lies in using it blindly, without physiological direction.

🩺 Key Concept — O₂ Debt vs. Anemia:

A patient with Hb 6 g/dL but stable, warm, normotensive may tolerate it.
A patient with Hb 8 g/dL but cold, hypotensive, tachycardic may die without transfusion.
It’s not the number — it’s the delivery.

⚙️ 1.2 Whole Blood vs Components — What You Really Get

Component Volume (mL) Contents Shelf Life Function
Whole Blood 450 ± 50 RBC + plasma + platelets (early) 21–35 days Best for major hemorrhage; supplies O₂ + factors
PRBC 250–300 RBCs + small plasma 35–42 days Raises Hb; minimal factors
FFP 200–250 All coag factors (no platelets) 1 year (frozen) Reverses coagulopathy
Cryoprecipitate 15–20 per unit Fibrinogen, VIII, XIII, vWF 1 year (frozen) Targets fibrinogen < 1 g/L
Platelets 50–70 (concentrate) Platelets + plasma 5 days Stops microvascular bleeding

In limited-resource centers:
Whole blood is often “component therapy in one bag” — but beware of storage decay:

  • Platelets gone after 6–8 hours
  • Factor V and VIII degrade after 5–7 days
  • Potassium and lactate rise with age

Hence, “fresh whole blood” (<24 h old) behaves like a balanced transfusion.

🩸 1.3 Quick Physics of Oxygen Delivery (DO₂ = CO × CaO₂)

Let’s decode why transfusion saves life — and why sometimes it doesn’t.

Oxygen Delivery (DO₂) = Cardiac Output (CO) × Arterial Oxygen Content (CaO₂)


CaO₂ = (1.34 × Hb × SaO₂) + (0.003 × PaO₂)

At normal values:
→ Hb = 10 g/dL, SaO₂ = 100%, PaO₂ = 100 mmHg
→ CaO₂ ≈ 13.4 mL O₂/dL blood

If Hb falls to 5 g/dL, even perfect saturation only yields ~6.7 mL O₂/dL.
No fluid or pressor can substitute this — only RBCs (or whole blood) restore O₂ capacity.

💡 Practical Use:

  • Hb <7 g/dL + instability = transfuse
  • Hb 7–9 g/dL + symptoms or ongoing bleed = consider
  • Hb >9 g/dL = reassess cause (do not chase normality)

In trauma or postpartum shock, when labs lag, use skin perfusion, lactate trend, and mental status as guides — transfuse for physiology, not numbers.

🌍 1.4 The Limited-Resource Mindset — Triage, Substitution & Safety

In many district hospitals:

  • Type-specific blood may take hours to crossmatch
  • Platelets are non-existent
  • Coagulation labs may not run after midnight

That’s where principled improvisation becomes lifesaving.

🔸 Principles:

  1. Stabilize First — airway, hemorrhage control, temperature
  2. Transfuse Judiciously — whole blood if active bleeding + pallor + shock signs
  3. Use FFP Early — replaces factors lost in dilutional coagulopathy
  4. Substitute When Possible:
    • Vitamin K for liver-related INR rise
    • TXA early in trauma or postpartum hemorrhage
    • Warm IV fluids for temperature preservation
  5. Never Delay for Perfection — “Good blood in time saves life better than perfect blood late.”

🧾 1.5 Bedside Card — Ten Rules That Prevent Fatal Errors

Rule Clinical Meaning
1️⃣ Identify the patient yourself before transfusion — never trust handwriting
2️⃣ Check blood group, expiry, integrity in front of witness
3️⃣ Never transfuse untyped blood unless immediately life-threatening
4️⃣ Warm blood if rapid transfusion or neonate involved
5️⃣ Record start time, volume, vital signs every 15 min
6️⃣ Stop immediately for any rash, fever, dyspnea, or hypotension
7️⃣ Keep IV line with normal saline only — never mix drugs
8️⃣ Calcium gluconate 10% every 3–4 units of blood
9️⃣ Maintain core temperature >36°C — hypothermia kills coagulation
🔟 If doubt arises: Stop, label, report, and preserve the bag for lab

🩺 Mnemonic:
“Check–Warm–Watch–Stop–Report” — five actions that define a safe transfusion culture.

🖼️ Visual Concept for Section 1 (to be included in the final layout)

  1. Diagram 1: Whole Blood vs Component Composition (color-coded layers)
  2. Diagram 2: Oxygen Delivery Curve (effect of Hb on DO₂)
  3. Infographic Card: Ten Bedside Rules (red-bordered, printable A5 format)

🧩 Clinical Pearl Box — Foundations

  • Hb is not oxygen delivery. Think in physiology, not numbers.
  • Whole blood ≠ old blood. Demand freshness for coagulopathy.
  • The safest transfusion is the one you truly need.
  • Every 10 minutes lost = rising lactate = rising mortality.
  • A transfusion given early and warm is worth more than two given late and cold.

⚗️ 2. Compatibility & Testing — Minimal Delay, Maximum Safety

🧬 2.1 ABO & Rh Basics — Explained in 2 Minutes

Every transfusion begins and ends with compatibility.
The ABO system is life or death — mistakes here kill faster than hemorrhage itself.

🩸 ABO Groups & Plasma Logic:

Recipient RBCs Can Receive From Plasma Can Be Given To
O O only All groups (universal plasma donor)
A A, O A, AB
B B, O B, AB
AB A, B, AB, O AB only

🔹 O-negative RBCs = universal donor
🔹 AB plasma = universal plasma donor

⚠️ Key Concept:

If you must guess — give O blood, not A or B, until type confirmed.
But in obstetric or childbearing-age women, O-negative only — Rh sensitization is permanent.

🧪 2.2 Type & Screen vs Crossmatch — What Each Means

Test Purpose Time Required Result Meaning
Type & Screen Determines ABO/Rh & looks for unexpected antibodies ~15–30 min Patient’s profile known; no blood selected yet
Crossmatch Tests patient’s plasma against donor RBCs ~45–60 min Confirms safe donor–recipient pairing

💡 Clinical Shortcut:

  • In emergencies, Type & Screen only + immediate-spin crossmatch can be enough.
  • Full antiglobulin (Coombs) crossmatch can follow once the patient stabilizes.

Always label samples at bedside.
Never accept a sample labeled outside your view — mislabeling kills.

🚨 2.3 Emergency Release — When Every Second Counts

When life outruns the lab:

🩸 If the patient’s blood type is unknown:

  • Adult male or postmenopausal female: O positive blood
  • Female of childbearing age / children: O negative blood
  • Massive bleed: use freshest whole blood available, not necessarily “universal,” if delay exceeds 20–30 min

Why O⁻ for fertile women?
Rh sensitization → future hemolytic disease of the newborn → preventable tragedy.

🕒 Golden Rule:

“If you can type and crossmatch in <10 min, wait.
If the patient will die in <10 min, transfuse.”

🔄 2.4 Switching from O to Type-Specific Safely

Once blood type known:

  1. Stop O supply as soon as type-specific units are available.
  2. Never mix O with another type simultaneously in one transfusion set — always flush with saline in between.
  3. Monitor first 15 minutes carefully — delayed hemolysis may appear subtle.

✅ Checklist for Safe Switch:

  • Confirm group twice from separate samples.
  • Replace O units only after both are verified.
  • Keep record of which bags were O vs specific.

🧭 2.5 Cut-Through Visuals: Compatibility at a Glance

(To be included in the published version)

🧩 Diagram 1: “Compatibility Wheel” — Red Cells & Plasma

  • Inner circle: RBC donor groups
  • Outer circle: Plasma compatibility
  • Arrows showing safe flows (O → all, AB plasma → all)

🩸 Diagram 2: “Emergency Release Flow”

  • Stepwise pathway:
    1. Identify urgency → 2. Choose O⁻ or O⁺ → 3. Label & record → 4. Switch to type-specific when ready.

🧪 Diagram 3: “Crossmatch Ladder”

  • From Type & Screen → Immediate Spin → Full Coombs
  • Time and safety scale beside each.

🧠 Clinical Pearls — Compatibility & Testing

  • The greatest transfusion risk is wrong patient, not wrong blood.
  • Label at bedside, not desk.
  • Never use plasma from O donors for A/B/AB recipients — it contains anti-A/B antibodies.
  • O⁺ is safer than O⁻ shortage panic — in males or elderly, Rh doesn’t matter.
  • Write start time, stop time, and reaction notes every single time.

💬 Real ICU Example

A 26-year-old female, postpartum, arrives with 3 L estimated blood loss.
Lab unavailable, donor fridge shows only:

  • 4 units O⁺, 2 units O⁻ whole blood, several FFP bags.

🩸 Decision:

  • Transfuse O⁻ whole blood immediately, 2 units in rapid sequence.
  • Draw sample for type & screen concurrently.
  • Once typed as A⁺, next 2 units → switch to A⁺ whole blood after 20-min confirmation.

Outcome:

  • Bleeding controlled.
  • No reaction.
  • Hb post-resuscitation: 8.5 g/dL.
  • Neonatal Rh prophylaxis given later.

Lesson:
⚖️ In real life, time trumps perfection — but only within clear physiology and safety logic.

🧾 Summary Table — Emergency Compatibility Quick Reference

Situation Preferred Blood Alternative Notes
Exsanguinating adult male O⁺ whole blood Any fresh whole blood Record Rh status
Exsanguinating female (fertile) O⁻ whole blood O⁺ (if no O⁻) + Anti-D later Never skip documentation
Known blood group, crossmatch pending Type-specific blood O same Rh Flush line before switch
Neonate (exchange transfusion) O⁻, CMV-safe O⁻ screened Warm to 37 °C
FFP shortage FFP same ABO group AB plasma Use smallest volume possible

📋 Section 2 Visual Summary

  1. Compatibility Wheel — color-coded safe arrows
  2. Crossmatch Ladder — time vs safety
  3. Emergency Pathway — O⁻/O⁺ release flow
  4. Bedside checklist — “Verify–Label–Transfuse–Switch–Record”

🧱 3. Components & Dosing You Actually Have

🩸 3.1 Whole Blood — When It Beats Components

What it is: ~450 mL containing RBCs + plasma (all factors) ± early platelets.
Best use: Active hemorrhage, obstetrics/trauma, low-supply settings.
Why it wins in scarcity: One bag restores O₂ capacity + factors + volume without dilution.

Practical points

  • Fresh whole blood (<24 h) behaves like a balanced transfusion; factor V/VIII decline with time.
  • Expected effect (adult): 1 unit ≈ Hb ↑ ~1 g/dL (varies with size/bleed).
  • Rate: Pressure bag/rapid infuser if shocked; warm to 37 °C.
  • Watch for: Citrate toxicity (ionized Ca²⁺ fall), hypothermia, K⁺ rise in older units.

Pearl: If platelets are unavailable, fresh whole blood + early FFP often outperforms PRBC-alone strategies.

🧬 3.2 Packed Red Blood Cells (PRBC) — Focused O₂ Capacity

What it is: 250–300 mL RBCs with minimal plasma.
Indication: Symptomatic anemia or hemorrhage where oxygen delivery is failing.

Dosing & effect

  • Adult: 1 unit → Hb ↑ ~1 g/dL (Hct ↑ ~3%).
  • Pediatric: 10–15 mL/kg → Hb ↑ ~2–3 g/dL.
  • Neonate: 10–15 mL/kg slow infusion; always warm.

Storage lesions to remember

  • ↓ 2,3-DPG (left-shift O₂ curve early), ↑ K⁺, microvesicles; clinical impact minimal in most—but rapid massive transfusion magnifies effects.

Red flags: PRBC without plasma in large volumes → dilutional coagulopathy; pair with FFP/cryo when bleeding persists.

🧪 3.3 Fresh Frozen Plasma (FFP) — Factor Replacement That Matters

What it is: 200–250 mL with all soluble coagulation factors (no platelets).
Indications: Coagulopathy with bleeding (or before urgent invasive procedure).

Dosing

  • Typical: 10–15 mL/kg, reassess INR/bleeding; in brisk hemorrhage 15–20 mL/kg.
  • Targets: Aim clinical hemostasis; if labs available, INR ≤ 1.5–1.7 is reasonable in active bleeding.

Tips

  • Start early when giving >3–4 units RBCs.
  • Avoid fluid overload—consider concentrated therapy (cryo) when the problem is fibrinogen.

❄️ 3.4 When Platelets Are Absent — Working Solutions

If you cannot obtain platelets:

  • Prefer fresh whole blood (early platelets present) rather than old PRBC.
  • Optimize fibrinogen (see cryo): aim ≥ 1.5–2.0 g/L (150–200 mg/dL) during bleeding.
  • TXA early (trauma/PPH) reduces fibrinolysis load (formal dosing in §5).
  • DDAVP 0.3 µg/kg IV over 20–30 min if uremia or antiplatelet use suspected.
  • Metabolic optimization: pH ≥ 7.2, temp ≥ 36 °C, iCa²⁺ normal → platelets/factors function better.
  • Mechanical hemostasis first (suturing, packing, uterotonics).

Reality check: For procedures, delay if possible when platelets <50 ×10⁹/L unless life-saving.

🧯 3.5 Cryoprecipitate — Fibrinogen Is the Quiet Hero

What it is (per unit ~15–20 mL): Fibrinogen (~150–250 mg), Factor VIII, XIII, vWF, fibronectin.
Indications: Hypofibrinogenemia in bleeding (trauma, obstetrics, DIC).

Dosing & targets

  • Adult loading: 10 units (“1 pool”) → fibrinogen ↑ ~0.8–1.0 g/L.
  • Rule of thumb: 1 unit per 10 kg (i.e., 7–10 units for average adult).
  • Peds/Neo: 1–2 units/10 kg (or 5–10 mL/kg of fibrinogen concentrate equivalent where available).
  • Targets in hemorrhage: ≥ 1.5–2.0 g/L (150–200 mg/dL); obstetrics often push to the higher end.

Pearl: In massive bleeding with no platelets, fibrinogen repletion often flips the bleeding curve.

🧰 3.6 Adjuncts That Actually Help (and When)

  • Vitamin K: 10 mg IV slow (≥30 min) for cholestasis/warfarin/liver-associated deficiency; not for acute dilutional coagulopathy alone.
  • Calcium:
    • Gluconate 10% 10 mL IV (≈ 90 mg elemental) every 3–4 units of blood, titrate to iCa²⁺; or
    • Calcium chloride 1 g IV via central line for severe hypocalcemia.
  • DDAVP (desmopressin): 0.3 µg/kg IV over 20–30 min for uremia or antiplatelet effect; consider in microvascular ooze.
  • rFVIIa (rescue only): 90 µg/kg IV; use after surgical control, temperature, pH, Ca²⁺, fibrinogen targets are optimized.
  • Aminocaproic acid: Antifibrinolytic alternative to TXA where TXA unavailable (formal ladder in §5).

📊 Table — “What To Use When You Cannot Get Platelets” (Bleeding Patient)

Problem What you can do Why it helps Caveats
Microvascular ooze, platelets unavailable Fresh whole blood (prefer <24 h old) Supplies early platelets + factors with RBCs Check for storage age; warm infusion
Hypofibrinogenemia (PPH/trauma/DIC) Cryo 10 units (adult) → repeat to target ≥ 1.5–2.0 g/L Restores fibrin scaffold Watch volume if multiple pools
Ongoing fibrinolysis TXA early (or aminocaproic) Stabilizes clot Avoid if suspected DIC with high thrombosis risk—use clinical judgment
Uremic/antiplatelet dysfunction DDAVP 0.3 µg/kg IV Boosts vWF release → platelet adhesion Short-lived (6–8 h), fluid-restrict
Dilutional coagulopathy FFP 15–20 mL/kg Replaces broad factors Volume load; combine with cryo if low fibrinogen
Acid–cold–low Ca²⁺ triad Warm patient, correct pH, give Ca²⁺ Restores enzyme/platelet function Monitor iCa²⁺ and core temp

🧪 Quick Dose Reference (tear-out style)

  • PRBC: Adult 1 unit → Hb ↑ ~1 g/dL; Peds/Neo 10–15 mL/kg
  • FFP: 10–15 mL/kg (up to 20 mL/kg if brisk bleeding)
  • Cryo: 10 units adult (or 1 unit/10 kg); target fibrinogen ≥ 1.5–2.0 g/L
  • DDAVP: 0.3 µg/kg IV over 20–30 min
  • Calcium: Ca-gluconate 10% 10 mL IV q3–4 units blood (or CaCl₂ 1 g centrally)
  • Warm all blood for rapid transfusion / neonates

🧠 Clinical Pearls — Components & Dosing

  • Platelets missing? Think fresh whole blood + cryo + TXA/DDAVP + correct temp/pH/Ca²⁺.
  • PRBC alone in hemorrhage worsens coagulopathy—pair with FFP/cryo.
  • Fibrinogen falls first in massive bleeding; correct it early.
  • Document doses and times—it guides the next hour’s decisions (and medicolegal safety).

🖼️ Planned Visuals for Section 3

  1. Stacked-bag graphic: Whole blood vs PRBC vs FFP vs Cryo (what each brings).
  2. Fibrinogen ladder: Starting value → how many cryo units to reach 2.0 g/L.
  3. No-Platelets Map: Decision path (Whole blood → Cryo → TXA/DDAVP → Optimize milieu).
  4. Pocket card: “Adjuncts that actually help” with dosing on one side.

🧭 4. Indications & Thresholds — Adult • Pediatric • Neonatal

🩺 4.1 Hemoglobin (Hb) Triggers — Context Is Everything

Forget the single “magic number.”
Transfusion thresholds must balance oxygen delivery (DO₂), tissue extraction, and individual vulnerability.

🔹 General Adult Triggers

Clinical Context Hb Trigger (g/dL) Rationale
Stable, non-bleeding ICU patient <7 Restrictive strategy safe; avoid overload
Active hemorrhage / shock <8 or symptomatic Hb less relevant; base on perfusion and lactate
Sepsis or major surgery (esp. cardiac) <8 Tissue hypoxia tolerance reduced
Acute coronary syndrome <9 Avoid myocardial O₂ debt
Head injury / neurocritical care 8–9 Maintain cerebral perfusion & O₂ gradient
Pregnancy / postpartum hemorrhage <7 (≥8 if unstable) Consider fetal O₂ and uterine tone
Chronic anemia (well-compensated) <6–7 if symptomatic Slow correction safer

💡 Principle: In bleeding, transfuse for physiology, not for numbers.
Monitor mental status, skin perfusion, lactate, urine output, and ScvO₂ if available.

🩸 4.2 Coagulation Targets — When Labs Lag or Lie

In low-resource hospitals, labs are often delayed, unavailable, or unreliable.
Hence, use clinical and visual triggers for plasma or cryo administration.

🔹 Clinical Clues of Coagulopathy

  • Oozing from IV sites / gums
  • Watery, non-clotting blood in suction
  • Prolonged bleeding after suture
  • Bleeding continues despite normal BP

🔹 When Labs Are Available (Targets During Bleeding)

Parameter Target What to Give if Below
INR ≤1.5–1.7 FFP 15–20 mL/kg
Fibrinogen ≥1.5–2.0 g/L (≥150–200 mg/dL) Cryo 10 U (adult) / 1 U / 10 kg
Platelets ≥50 × 10⁹/L (≥100 × 10⁹/L if neuro/surgery) Platelets (or WB + FFP if absent)
Temperature ≥36 °C Warm fluids, blankets
Ionized Ca²⁺ >1.0 mmol/L Ca gluconate 10 mL 10% q3–4 U

⚠️ Never chase lab normality—aim for hemostasis.
If bleeding stops, your target is met.

👶 4.3 Pediatric & Neonatal Thresholds

Children and neonates differ by total blood volume and Hb adaptation.
Use mL/kg, not “units.”

🔸 Pediatric (≥1 month)

Situation Hb Trigger PRBC Dose Plasma / Cryo
Stable <7 10–15 mL/kg –
Active bleed / shock <8 15 mL/kg FFP 10–15 mL/kg
Cardiac disease <9 10–15 mL/kg FFP 15 mL/kg
DIC / coagulopathy – – Cryo 1 U / 10 kg

Reassess after every 10 mL/kg — children respond fast and can be easily overloaded.

🔸 Neonatal (≤28 days)

Indication Hb Trigger (g/dL) PRBC Volume Notes
Preterm (<28 wk) stable <10 10–15 mL/kg Transfuse slowly (3–4 h)
Preterm with resp. distress / sepsis <12 10–15 mL/kg Aim for O₂ delivery
Exchange transfusion (HDN) – 160–180 mL/kg total Use O⁻ CMV-safe, warmed
Major bleed <13 15 mL/kg Combine with FFP 10 mL/kg
Fibrinogen <1 g/L – Cryo 5 mL/kg Repeat as needed

🍼 Rule of thumb: Neonatal blood volume ≈ 80–100 mL/kg.
Always use infusion pump and blood warmer.

🔬 4.4 When to Transfuse FFP, Cryo, Platelets

Component When to Give Dose Notes
FFP Oozing / INR > 1.5 10–15 mL/kg Use early if labs delayed
Cryo Fibrinogen < 1.5 g/L 10 U adult / 1 U / 10 kg Add TXA for synergy
Platelets <50 × 10⁹/L (surgery) / <100 × 10⁹/L (neuro/OB) 1 unit / 10 kg Use WB+FFP if absent

🧮 4.5 Pediatric Dose Wheel (Quick Reference)

(to be visualized as circular chart in the final guide)

Weight (kg) PRBC (mL) FFP (mL) Cryo (mL)
5 50 50 20
10 100 100 40
15 150 150 60
20 200 200 80
30 300 300 120
40 400 400 160

Each ring on the wheel = +5 kg increment, color-coded for component type.

🧠 Clinical Pearls — Indications & Thresholds

  • Transfuse the patient, not the number.
  • Each 10 min delay in critical bleed = ↑ mortality; treat clinical picture.
  • Always pair transfusion with reassessment.
  • Children compensate silently—tachycardia is late.
  • Obstetric bleeding ≠ same as trauma: fibrinogen drops earlier; replace fast.
  • Document trigger + rationale every time—protects patient and clinician.

🩺 Visual Concepts for Section 4

  1. Hb trigger pyramid: from restrictive (7 g/dL) base → liberal (9 g/dL) apex by vulnerability.
  2. Clinical trigger map: perfusion signs guiding transfusion before labs.
  3. Pediatric dose wheel: mL/kg rings for quick recall.
  4. “Bleeding Stops = Target Met” card — printable A6 bedside reminder.

🚨 5. Massive Hemorrhage Protocol (MHP/MTP) — Low-Supply Hospitals

Goal: Stop bleeding fast, restore O₂ delivery + clotting + perfusion, and avoid the lethal triad (hypothermia, hypocalcemia, acidosis).
Mindset: Whole-blood-forward, early fibrinogen, TXA in time, and ruthless logistics.

🛎️ 5.1 When to Activate — No Lab Needed

Trigger MHP immediately if ANY of the following apply (pick the earliest you see):

  • Physiology: SBP <90 mmHg or MAP <65 + tachycardia; Shock Index >1.0 (HR/SBP).
  • Bleeding rate: EBL >150 mL/min (soaked laparotomy pads, pooling on floor, “watery” suction).
  • Transfusion pace: ≥ 2 units in 30 min or >4 units anticipated.
  • Mechanism + instability: Penetrating torso trauma with hypotension, pelvic fracture with instability.
  • Obstetrics: PPH >1000 mL with ongoing bleed, atony unresponsive to uterotonics, PAS rupture.
  • Clinical DIC signs: Oozing from lines + mucosal bleeding + poor clot formation.

🧠 Rule: Don’t wait for INR or fibrinogen. Activate, then refine.

🩸 5.2 Strategy — Whole-Blood-Forward vs 1:1:1 (No Platelets on Site)

If whole blood available (preferred):

  • Cycle A (adult): 1 unit WB → 1 unit FFP → 1 unit WB → 1 unit FFP, repeat.
    • Rationale: WB supplies RBCs + some factors; FFP preserves coagulation as platelets are absent.
  • Add cryo early if bleeding brisk or obstetric: 10 units (adult) to target fibrinogen ≥1.5–2.0 g/L.

If PRBC + FFP only (no WB):

  • Cycle B: PRBC : FFP = 1:1 until bleeding slows, then add cryo.
  • Avoid PRBC-only spirals → dilutional coagulopathy worsens hemorrhage.

Pediatric (shock/trauma/PPH equivalents):

  • 10–15 mL/kg PRBC alternating with 10–15 mL/kg FFP; early cryo 1 U/10 kg.

🌟 Obstetric emphasis: Fibrinogen falls early. Cryo upfront changes the curve.

⚖️ Supplement: The 1 : 1 : 1 Rule — Balanced Resuscitation Demystified

🔹 Origin of the Rule

Developed from military and trauma research (PROMMTT, PROPPR trials), the 1 : 1 : 1 ratio means:

1 unit RBC : 1 unit FFP : 1 unit Platelets

It approximates the composition of whole blood, restoring red cells, plasma factors, and platelets in balance.

Goal: To prevent or reverse the “lethal triad” (acidosis + hypothermia + coagulopathy) that develops when RBCs are given alone.

🔹 Physiologic Rationale

  • RBCs → oxygen-carrying capacity

  • FFP → coagulation factors

  • Platelets → cellular clot foundation
    A 1 : 1 : 1 ratio delivers near-physiologic clotting substrate density and maintains hemostasis in massive transfusion.

🔹 Limitations in Resource-Limited Settings

Most district or provincial hospitals lack platelets or have limited FFP stock.
Therefore, the “true” 1 : 1 : 1 is often impossible — but its principle can be preserved.

🩸 Adapted Practical Models

Scenario Realistic Ratio Comment
Whole blood available Whole Blood : FFP = 1 : 1 Closest physiologic match; includes early platelets if <24 h old
No platelets, limited FFP PRBC : FFP : Cryo = 1 : 1 : 1 (substitute) Cryo provides fibrinogen; use TXA to curb fibrinolysis
Only WB Cycle 1 WB → 1 FFP → repeat Maintain balance; add Ca²⁺, warmth, and TXA
Platelets obtainable later Initial WB/FFP, then add platelets (if ≥2 U RBCs given) Restores full 1 : 1 : 1 effect once supply catches up

Rule adaptation:
Even if platelets are missing, the concept stands — replace RBCs + factors + fibrinogen proportionally, not sequentially.

🔹 When to Start Balanced Resuscitation

Activate the 1 : 1 : 1 cycle after the first 2–3 U RBCs when bleeding is ongoing or uncontrolled.
Do not wait for INR or platelet counts — they lag behind reality.

🔹 Clinical Example

A 28-year-old woman with PAS loses ~2.5 L rapidly.
Blood fridge: only WB and FFP, no platelets.

Action Plan

  • Start WB + FFP 1 : 1 immediately.

  • Add cryo (10 U) at 1.5–2 g/L fibrinogen target.

  • TXA 1 g IV within 3 h of delivery.

  • Ca-gluconate 10 mL 10 % after every 3–4 U WB.
    → Effective functional 1 : 1 : 1 even without platelets.

🔹 Take-Home Summary

Principle Practical Execution
Balance cells : factors : platelets ≈ 1 : 1 : 1 Substitute cryo / fresh WB if platelets absent
Start early (≥ 3 U RBCs or active hemorrhage) Don’t wait for INR or count
Keep patient warm + Ca²⁺ + TXA Supports clotting cascade
Switch back to type-specific when stable Prevent wastage and mismatch
Audit ratio post-case Improves team discipline

🧠 Pearl

The number “1 : 1 : 1” is symbolic.
The real goal is coagulation symmetry — to replace what is being lost together, not in fragments.

⏱️ 5.3 Antifibrinolytics — TXA First, Aminocaproic if TXA Unavailable

Tranexamic Acid (TXA)

  • Trauma (CRASH-2 logic): 1 g IV over 10 min, then 1 g IV over 8 h.
    • Must start ≤3 h from injury (earlier is better).
  • PPH (WOMAN trial logic): 1 g IV over 10 min, repeat 1 g if bleeding continues after 30 min or restarts within 24 h; start ≤3 h from birth.

Aminocaproic Acid (fallback)

  • Load: 4–5 g IV over 1 h (or 100 mg/kg).
  • Infusion: 1 g/h for 8 h (or 10–15 mg/kg/h).
  • Avoid if strong concern for DIC with high thrombosis risk—use clinical judgment.

💡 Give antifibrinolytic early (after activation, not after failure).

🧊⚡🧪 5.4 The Lethal Triad — Make It Fixable

❄️ Hypothermia (T <36 °C)

  • Warm all blood/fluids (37–40 °C), forced-air blanket, increase OR temp.
  • Every 1 °C drop impairs enzymes/platelets → bleeding escalates.

🧪 Hypocalcemia (Citrate toxicity)

  • Calcium gluconate 10% 10 mL IV every 3–4 units of blood (titrate to iCa²⁺ >1.0 mmol/L).
  • If crashing/central line: Calcium chloride 1 g IV.
  • Watch ECG (QTc, hypotension).

🌡️ Acidosis (pH <7.2)

  • Stop the bleed (surgery/packing), ventilate adequately, perfuse with blood/FFP/cryo.
  • Bicarbonate only for severe, life-threatening acidosis after source control (pH ≲7.1).

🧠 Mantra: Warm → Calcium → pH — restore the clotting environment.

🗂️ 5.5 Rapid Checklists (Single-Page Cards)

🟦 OR – MHP Quick Card

  • ✅ Call MHP; announce time zero
  • ✅ Pack/Clamp/Compress; hemostasis team lead assigned
  • ✅ Cycle A/B started (WB/FFP or PRBC/FFP)
  • ✅ TXA now (if within window)
  • ✅ Cryo early (esp. obstetrics/trauma)
  • ✅ Warm patient & blood, forced air on
  • ✅ Ca²⁺ after 3–4 units, repeat by iCa²⁺
  • ✅ Reassess q10 min: BP/MAP, UO, mental status, lactate trend
  • ✅ Document units, times, reactions; prep for switch to type-specific

🟩 ER – MHP Quick Card

  • ✅ Two large-bore IVs or RIC/IO; send type & screen (bedside label)
  • ✅ Activate TXA pathway and Cycle A/B
  • ✅ Whole blood if available; else PRBC/FFP 1:1
  • ✅ Warming blanket + fluid warmer; monitor temp
  • ✅ Ca²⁺ protocol engaged
  • ✅ Prepare transfer to OR/ICU; keep running totals & timestamps

🟧 ICU – MHP Quick Card

  • ✅ Confirm ongoing source (re-bleed? surgical call?)
  • ✅ Continue balanced replacement + cryo to targets
  • ✅ Antifibrinolytic per window; avoid late TXA beyond 3 h in trauma/PPH
  • ✅ MAP ≥65 with blood first; vasopressors only after volume/bleeding addressed
  • ✅ Labs if available: Hb, fibrinogen, INR, iCa²⁺, lactate (but don’t wait to treat)
  • ✅ Stop criteria considered; de-escalate to stewardship (see §10)

🧰 5.6 MHP Box Contents — Pack It Once, Use It Fast

  • Color-coded binder: Activation script, Cycle A/B schemas, dosing ladders
  • Line kit: 2 large-bore cannulas, pressure bags, rapid infuser tubing
  • Warmers: Fluid/blood warmers, forced-air device blankets
  • Med tray: TXA vials, Ca-gluconate 10%, CaCl₂ (for central), DDAVP ampoules
  • Cryo protocol sheet + thaw instructions; FFP thaw times
  • Documentation board: Timestamps, units, vitals q10–15 min, reactions

⛔ 5.7 Stop / Taper Criteria — Know When You’re Winning

  • SBP/MAP stable without escalating pressors
  • Bleeding visibly slowed/stopped; suction clears, no new pooling
  • Skin perfusion improves; UO ≥0.5 mL/kg/h (adults)
  • Lactate falling (or base deficit improving)
  • If labs present: Fibrinogen ≥1.5–2.0 g/L, INR ≤1.5–1.7, iCa²⁺ >1.0, T ≥36 °C

Then de-activate MHP, hand off to stewardship & audit (Section 10).

🧠 Clinical Pearls — MHP in Scarcity

  • Fresh whole blood + FFP + cryo beats PRBC-alone every time in hemorrhage.
  • Antifibrinolytic early or not at all (≤3 h window).
  • Fibrinogen is the early limiter—replace to ≥2.0 g/L in obstetrics if possible.
  • Warmth and calcium are drugs—dose them.
  • Documentation saves lives later (trend recognition, medicolegal clarity).

🖼️ Planned Visuals for Section 5

  1. “Press Here” MHP Button Flowchart — activation → Cycle A/B → TXA → Cryo → Triad fixes.
  2. Whole-Blood-Forward Algorithm — rural vs tertiary branches.
  3. Lethal Triad Dashboard — temp, iCa²⁺, pH quick dials.
  4. One-page OR/ER/ICU Cards — bold, laminated, color-coded.
  5. TXA/Aminocaproic Ladder — timing windows and doses.

🌺 6. Obstetric Hemorrhage — Beyond “PPH”: PAS, Rupture, Atony

Massive obstetric bleeding is unique: coagulopathy develops early, fibrinogen crashes first, and blood loss is often underestimated by 30–50%.
In limited-resource hospitals, smart sequencing — not technology — saves mothers.

👶 6.1 Classification & Risk Staging — The 4Ts Framework

Cause Mechanism Classic Clues Example
Tone (Atony) Uterine muscle fails to contract Soft boggy uterus, gush of blood After long labor, multiple gestation
Tissue Retained placenta or membranes Fragments on inspection, ultrasound Retained cotyledon
Trauma Genital tract or uterine tears Bright red bleeding, firm uterus Episiotomy, rupture
Thrombin Coagulopathy (DIC, HELLP, sepsis) Oozing, non-clotting blood Abruptio placentae, IUFD

🔹 Risk Stratification:

  • Stage 1: >500 mL vaginal / >1000 mL cesarean
  • Stage 2: Continuing bleed + tachycardia / pallor
  • Stage 3: Hypotension, shock, coagulopathy
  • Stage 4: DIC or cardiac arrest

🩺 At Stage 2, activate MHP (see Section 5).
Waiting until Stage 3 is how PPH becomes mortality.

🩸 6.2 Placenta Accreta Spectrum (PAS) — Accreta | Increta | Percreta

Definition: Abnormal adherence of placenta to uterine wall due to absent decidua basalis.
Spectrum:

  • Accreta: Attached to myometrium
  • Increta: Invades myometrium
  • Percreta: Penetrates serosa ± bladder

🩹 Pre-operative Planning in Low-Supply Settings

  • Identify high-risk mothers early: previa, prior C-section, anterior placenta, IVF, age > 35.
  • Arrange whole blood donors in advance (family, directed).
  • Prepare cryo (10 U), TXA 1 g IV on standby, FFP thawed.
  • Keep 2 large-bore IVs, urinary catheter, warming devices ready.
  • Coordinate with anesthesiologist + surgeon + blood bank before incision.

Mental model: Treat PAS as a scheduled emergency.
Every minute you gain before delivery buys coagulation integrity later.

⚙️ 6.3 Intra-operative Playbook — Whole Blood + FFP Cycles

Step Action Key Detail
1️⃣ TXA 1 g IV before or at incision Repeat once after 30 min if bleeding continues
2️⃣ Early whole blood (fresh) 1 unit WB ↔ 1 unit FFP cycle
3️⃣ Cryo after 2 cycles 10 U adult (1 U/10 kg)
4️⃣ Ca²⁺ replacement 10 mL 10% Ca-gluconate q3–4 units WB
5️⃣ Warm everything 37–40 °C blood + forced air
6️⃣ Monitor fibrinogen visually “Watery” blood → give cryo + FFP
7️⃣ Anticipate DIC early If oozing despite pressure, skip to Section 7 protocol

If placenta cannot be separated safely:
→ Proceed directly to subtotal or total hysterectomy.
→ Don’t attempt piecemeal removal in uncontrolled bleed.

🧠 6.4 Uterotonics vs Blood Timing — The Tightrope

Sequence matters more than drugs.

Step Intervention Purpose
1️⃣ Oxytocin 10 IU IV slowly, then 40 IU in 1 L NS over 4 h Baseline uterotonic
2️⃣ If atony persists → Ergometrine 0.2 mg IM (q15 min × 3 max)** Avoid in hypertension
3️⃣ Add Misoprostol 800–1000 µg PR Heat-stable backup
4️⃣ If no tone + bleeding: escalate to WB/FFP cycle + TXA Prevent dilutional loss
5️⃣ If refractory: balloon tamponade → B-Lynch → hysterectomy Life over uterus

💡 Timing tip:
Transfusion follows tone. Blood before uterotonics = wasted; uterotonics without blood = futile.

🧭 6.5 PAS Field Algorithms (Rural → Tertiary)

Rural or District Hospital Algorithm (no platelets, limited cryo): 1️⃣ Identify risk → alert blood bank → arrange fresh whole blood + FFP.
2️⃣ TXA 1 g IV immediately.
3️⃣ Start WB:FFP 1:1 as bleeding begins.
4️⃣ If persists → add cryo when available (10 U adult).
5️⃣ If unstable → transfer while transfusing (keep warm, document units).

Tertiary Center Algorithm: 1️⃣ Planned multidisciplinary team.
2️⃣ Cell salvage + autotransfusion if allowed.
3️⃣ MHP pack ready (WB, FFP, cryo, Ca²⁺).
4️⃣ Early balloon occlusion / vascular clamps if trained team.
5️⃣ Proceed to hysterectomy at first sign of uncontrolled invasion.

📊 6.6 Fibrinogen in Obstetrics — The Early Marker

  • In PPH, fibrinogen < 2 g/L predicts progression to severe hemorrhage.
  • Replace to ≥ 2 g/L early (prefer 10 U cryo ≈ 2–4 g fibrinogen).
  • If cryo unavailable: FFP 15–20 mL/kg + TXA + vitamin K 10 mg IV.

🧩 6.7 Quick Reference Table — Obstetric Transfusion Plan

Component First Dose Repeat Rule Remarks
WB 1 unit → repeat as needed After every 15–20 min if unstable Prefer <24 h old
FFP 15 mL/kg (≈ 3 U) After every 3–4 U WB Watch volume
Cryo 10 U adult Target fibrinogen ≥ 2 g/L Early in PPH
TXA 1 g IV × 2 (≤ 3 h) Repeat if rebleed < 24 h Start early
Ca²⁺ 10 mL 10% q3–4 U Maintain iCa²⁺ > 1.0 mmol/L Mandatory
Warmth 37–40 °C Continuous Prevent coagulopathy

🩺 6.8 When Hysterectomy Is the Blood-Sparing Choice

  • Failed tone + no cryo/platelets + invasion = do not delay.
  • Decision ideally < 60 min from PPH recognition.
  • Subtotal hysterectomy faster, less blood loss if cervix intact.
  • Document indication → debrief family with empathy.

⚖️ In obstetric hemorrhage, saving the woman is the first act of motherhood.

🧠 6.9 Clinical Pearls — Obstetric Hemorrhage

  • Fibrinogen is the first factor to fall—replace to ≥ 2 g/L early.
  • TXA within 3 h halves mortality; after that, it doesn’t help.
  • Uterotonics and transfusion are partners, not competitors.
  • Atony + watery blood = coagulopathy starting—move to WB + FFP + cryo.
  • Plan PAS like trauma—team, blood, timing, discipline.
  • Document and debrief every severe case for audit (see §10).

🖼️ Planned Visuals for Section 6

  1. “4 Ts Wheel” — Tone, Tissue, Trauma, Thrombin with interventions.
  2. PAS Decision Tree — district → tertiary flow.
  3. Intra-op Playbook Chart — TXA + WB/FFP/cryo sequence.
  4. Uterotonic Timeline — drug sequence with transfusion trigger icons.
  5. Fibrinogen Meter — color bar < 1 → critical; 2 = safe.

🧩 7. Disseminated Intravascular Coagulation (DIC) — Diagnose Before Labs; Treat While They’re Cooking

⚠️ 7.1 The Concept in One Line

DIC is not a disease — it’s the body’s desperate, dying attempt to clot and bleed at once.

It’s the final pathway of severe physiologic insult: trauma, sepsis, abruption, amniotic embolism, liver failure, or shock.
Clots form everywhere, consuming factors and platelets → then bleeding erupts from everywhere.

🩸 7.2 Recognizing DIC Clinically — Before Labs Arrive

In low-resource ICUs, clinical pattern recognition outruns laboratory delay.

Visual & Bedside Clues Interpretation
Persistent oozing from IV or surgical sites Early microvascular consumption
Watery, non-clotting blood in suction or syringe Factor depletion (esp. fibrinogen)
Petechiae / ecchymoses / mucosal bleeding Platelet collapse
Darkening fingertips, acrocyanosis Microthrombi formation
Falling BP despite transfusion Capillary leak, shock coagulopathy

🔴 Mnemonic:
Ooze + Watery Blood + Shock = Treat for DIC.
Do not wait for INR or fibrinogen report.

🧪 7.3 Laboratory Confirmation (When Available)

Parameter DIC Trend Typical Cutoff
Platelet count Falling <100 ×10⁹/L
PT / INR Prolonged INR >1.5–2.0
aPTT Prolonged >1.5 × control
Fibrinogen Decreased <1.0 g/L
D-dimer / FDPs Markedly ↑ >5× normal
Blood film Schistocytes Fragmented cells present

🧩 ISTH DIC Score (when all labs available):

  • Platelets <50 = 2 pts

  • Fibrinogen <1 = 1 pt

  • D-dimer ↑↑ = 2 pts

  • PT prolongation >6 s = 2 pts
    → Score ≥5 = overt DIC.

🧬 7.4 Treat While Labs Are Cooking — Replace What’s Burning

🔹 Step 1: Stop the Trigger

  • Control hemorrhage or infection (deliver placenta, evacuate uterus, drain abscess).

  • In trauma, activate MHP immediately.

  • In sepsis, begin antibiotics + source control.

🔹 Step 2: Replace Coagulation Factors & Fibrinogen

Component Dose Target
FFP 15–20 mL/kg INR ≤1.5
Cryo 10 U adult (1 U/10 kg) Fibrinogen ≥1.5–2 g/L
Whole Blood (fresh) 1 U per cycle Adds RBCs + factors
Platelets (if available) 1 pool / 10 kg >50 ×10⁹/L
Vitamin K 10 mg IV – If hepatic cause

💡 In absence of platelets → rely on fresh WB + FFP + cryo.
TXA only if fibrinolysis dominates (trauma/PPH type); avoid in sepsis-driven DIC with multi-organ thrombosis.

🔹 Step 3: Support Perfusion & Core Physiology

  • Maintain Temp ≥36°C — enzymatic clotting stops below that.

  • Calcium 10% 10 mL IV q3–4 units (keep iCa²⁺ >1 mmol/L).

  • Correct pH ≥7.2, optimize oxygenation.

  • Avoid overzealous fluids — they dilute more factors.

  • Heparin only in chronic compensated DIC (e.g., retained dead fetus >4 weeks, vascular malignancy), not in bleeding phase.

🧭 7.5 DIC vs Dilutional vs Liver Failure — Quick Differentiation

Feature DIC Dilutional Coagulopathy Liver Failure Coagulopathy
Onset Acute (hours) During resuscitation Gradual (days)
Platelets ↓↓↓ ↓ ↓ or normal
Fibrinogen ↓↓↓ (<1 g/L) ↓ Normal / ↑ (acute phase)
D-dimer/FDP Very ↑↑↑ Mild ↑ ↑
Peripheral smear Schistocytes Normal Target cells
Treatment priority Stop trigger + replace factors Replace FFP + cryo Treat liver, Vit K, FFP PRN

🧰 7.6 Bedside Algorithm — “DIC Before Labs”

1️⃣ Identify: Bleeding + oozing + watery blood.
2️⃣ Treat trigger: deliver, debride, or drain.
3️⃣ Start FFP 15–20 mL/kg.
4️⃣ Add cryo 10 U (adult) if suspected fibrinogen <1.5 g/L.
5️⃣ Use fresh WB if platelets absent.
6️⃣ Calcium + warmth + pH control.
7️⃣ TXA only in trauma-type or early obstetric pattern.
8️⃣ Reassess q30–60 min.
9️⃣ Stop criteria: bleeding controlled, skin perfused, HR/BP stable.

🧾 7.7 Quick Treatment Summary Table

Situation What to Give Dose Remarks
Oozing, watery blood FFP + Cryo 15–20 mL/kg + 10 U Replace broad factors + fibrinogen
No platelets available Fresh WB 1 U per 15–30 min Contains early platelets + RBCs
Obstetric DIC TXA 1 g IV + Cryo – Replace fibrinogen early
Sepsis DIC FFP + source control 15–20 mL/kg Avoid TXA
Chronic DIC Heparin 5,000 U SC q8–12 h – Only if non-bleeding
Hypocalcemia Ca-gluconate 10% 10 mL IV q3–4 units blood Maintain iCa²⁺ ≥1 mmol/L

🧠 7.8 Clinical Pearls — DIC in Resource-Limited Settings

  • Recognize before confirmation. Oozing = action time.

  • Fibrinogen <1.0 g/L = transfuse now, don’t wait.

  • TXA is not for all DIC — only use if fibrinolytic-type bleeding dominates.

  • Warmth, calcium, and pH correction are your silent transfusions.

  • Never transfuse blindly—treat the cause first, not just the coagulation numbers.

  • Every DIC survivor teaches your team timing.

🖼️ Planned Visuals for Section 7

  1. DIC Recognition Matrix: bedside vs dilutional vs liver failure.

  2. Flowchart: “DIC Before Labs” — visual decision pathway.

  3. “Watery Blood” microscope illustration showing loss of clot mesh.

  4. ISTH DIC Score Bar — quick scoring infographic.

  5. FFP + Cryo Cycle Poster — simple color-coded replacement flow.

🧪Appendix 7-A – Reliable Bedside Coagulation Testing (Field-Validated)

Only tools with guideline or peer-reviewed support are included. Anything improvised (e.g., “paper-drop/white-paper halo,” earlobe bleeding time) is excluded due to poor accuracy and lack of validation.

1) 20-Minute Whole Blood Clotting Test (20WBCT) — validated screen for gross defibrination

How: 2 mL fresh venous blood into a clean, dry, plain glass tube at room temp. Do not shake. Check at 20 minutes.
Interpretation: No clot at 20 min = severe coagulopathy/defibrination → urgent fibrinogen/FFP replacement.
Evidence: Recommended in WHO snakebite management and widely validated as a simple bedside detector of incoagulable blood; accuracy correlates with very low fibrinogen. (Research Edinburgh)

2) Warm Glass-Tube Bedside Clot Test (“red-top/Lee–White style”) — field standard in PPH programs

How: 2 mL venous blood in a clean, dry glass tube; keep warm in the fist (~37 °C); gently tip at 4 minutes, then every minute until a stable clot forms (tube invertable).
Interpretation: Failure to clot by ~7–8 minutes or a friable/soft clot suggests consumptive coagulopathy / hypofibrinogenemia → start FFP (15–20 mL/kg) ± cryoprecipitate while definitive labs are pending.
Evidence: Described and taught in obstetric hemorrhage manuals and national PPH guidelines as a rapid bedside assessment when labs lag, with explicit technique and 7-minute failure threshold. (Use glass, not plastic.) (media.path.org)

3) Viscoelastic Testing (TEG/ROTEM) — point-of-care when available

Why: Rapidly identifies fibrinogen deficit, platelet dysfunction, and hyperfibrinolysis to target products (FFP/cryo/platelets/TXA).
Setting: Trauma/PPH/major surgery centers with devices.
Evidence: Practice management guideline (EAST) and reviews support VET-guided resuscitation in bleeding patients; growing obstetric data show utility in PPH (especially for low fibrinogen). (east.org)

4) What we do not include (not evidence-based for decision-making)

  • “Paper-drop / white-paper halo” blot: qualitative only; no validated thresholds → exclude from protocols. (Use tests above instead.)

  • Bleeding time (Duke/Ivy; earlobe/forearm pin-prick): obsolete, unreliable, and not predictive of peri-hemorrhage risk or transfusion needs → do not use. (BioMed Central)

5) Quick bedside flow (print card)

  1. Heavy bleed + oozing pattern? → Do Warm Glass-Tube Test now.
     • No/soft clot ≥7–8 min → Give FFP 15–20 mL/kg ± cryo and continue definitive care. (media.path.org)

  2. Suspect profound defibrination (incoagulable blood)? → Do 20WBCT.
     • Unclotted at 20 min → Treat as severe factor/fibrinogen depletion urgently. (Research Edinburgh)

  3. If VET available → target therapy (e.g., low FIBTEM A5 → cryo/fibrinogen). (east.org)

6) Notes on technique & pitfalls

  • Glass only for bedside clot tests; plastics can spuriously prolong or prevent clotting. (PubMed)

  • Run tests on fresh venous blood; avoid anticoagulant contamination.

  • Bedside tests do not replace full labs/VET where available; they bridge the gap so treatment isn’t delayed. RCOG/FIGO and WHO initiatives emphasize early detection/treatment bundles for PPH while quantitative loss is tracked. (RCOG)

⚠️ 8. Transfusion Reactions — See It, Stop It, Fix It

Prime directive: If a patient deteriorates during a transfusion, assume a reaction until proven otherwise.
First 60 seconds rule: STOP transfusion → KEEP IV open with NS → CALL for help → CHECK patient ID & bag → ASSESS ABCs.

⏱️ 8.1 Immediate Actions (Universal Algorithm) — “Stop–Check–Support–Notify”

  1. STOP transfusion (leave line in).

  2. CHECK identifiers (patient, unit, group, expiry, integrity).

  3. SUPPORT ABCs: oxygen, airway, IV fluids, epinephrine kit ready.

  4. NOTIFY blood bank + clinician; send reaction packet:

    • Post-reaction sample (EDTA + serum),

    • Direct antiglobulin test (DAT/Coombs),

    • Hemolysis labs: plasma free Hb, bilirubin, LDH, haptoglobin,

    • Urinalysis for Hb,

    • Culture of unit if fever/sepsis suspected.

  5. DOCUMENT vitals q15 min; save the bag/tubing for investigation.

  6. RESTART only if the cause is non-hemolytic/minor and team agrees.

🖼️ One-Page Card (to print): “Stop–Check–Support–Notify” with tick boxes.

🧭 8.2 Rapid Bedside Triage by Dominant Sign

Dominant Sign First Thoughts Next 2–3 Actions
Fever/chills within 1–2 h FNHTR vs sepsis vs hemolysis Stop; antipyretic; culture unit & patient; send hemolysis labs + DAT
Hypotension + back/chest pain Acute hemolytic until proven otherwise Stop; NS bolus; maintain urine >1 mL/kg/h; labs + DAT; escalate
Dyspnea + hypoxemia TRALI vs TACO (see 8.4) Stop; CXR; ABG if possible; diuretics only if TACO likely
Urticaria/itching Mild allergic Stop briefly; antihistamine; may restart if symptoms resolve
Wheezing/stridor/hypotension Anaphylaxis Stop; IM epinephrine 0.3–0.5 mg (peds 0.01 mg/kg); airway; steroids; fluids
Fever >39°C, rigors, shock Septic reaction (platelets/WB/FFP) Stop; broad-spectrum antibiotics; culture unit & patient; ICU

🧨 8.3 Acute Hemolytic Transfusion Reaction (AHTR) — Time-Critical

Clues: fever, back pain, chest tightness, hemoglobinuria, hypotension, DIC.
Cause: usually ABO mismatch or hemolysin antibodies.

Management (do all):

  • Stop transfusion; wide-open NS to maintain urine ≥1 mL/kg/h, consider furosemide 20–40 mg IV if needed.

  • Send DAT, hemolysis labs, urinalysis.

  • Treat shock/DIC per Sections 5 & 7 (FFP/cryo as indicated).

  • Do not restart any blood until investigation clears.

Prevention pearls: bedside ID check, separate sampling, never relabel off the bedside.

🌬️ 8.4 TRALI vs TACO — The Bedside Split

Feature TRALI (Transfusion-Related Acute Lung Injury) TACO (Transfusion-Associated Circulatory Overload)
Onset During or ≤6 h after transfusion During or ≤6 h after (often faster with rapid infusion)
BP Normal/low High or rising
JVP/Edema Usually normal Elevated JVP, S3, peripheral edema
Fever Common Rare
CXR Bilateral non-cardiogenic edema Cardiogenic edema/vascular congestion
BNP/NT-proBNP Usually normal Elevated
Response to diuretics Minimal Improves
Risk groups Multiparous donor plasma; critically ill recipients Elderly, renal/cardiac disease, rapid/large-volume transfusion

Immediate approach:

  • Stop transfusion, oxygen/PEEP as needed.

  • If hypertension, raised JVP, BNP high → TACO → IV furosemide + slow future transfusions.

  • If fever, hypotension, pink frothy sputum, normal BNP → TRALI → supportive ventilation; avoid diuretics as primary.

🖼️ Planned Visual: Side-by-side TRALI vs TACO diagnostic lane with icons (BP cuff, lungs, JVP line, BNP).

🤧 8.5 Allergic & Anaphylactic Reactions

Mild allergic (urticaria, pruritus, no dyspnea):

  • Stop briefly; diphenhydramine 25–50 mg IV/PO (peds 0.5–1 mg/kg).

  • If resolved and no other signs, restart cautiously.

Anaphylaxis (hypotension, bronchospasm, airway edema):

  • IM epinephrine 0.3–0.5 mg (1:1000) → repeat q5–10 min as needed.

  • High-flow O₂; IV fluids; methylprednisolone 125 mg IV; H1/H2 blockers.

  • For IgA deficiency with anti-IgA: use washed RBCs/plasma-reduced components in future.

🌡️ 8.6 Febrile Non-Hemolytic Transfusion Reaction (FNHTR)

Clues: isolated fever/chills during/after transfusion, no hemolysis.
Action: Stop; exclude hemolysis/sepsis; paracetamol; consider leukoreduced or pre-med in future.
Tip: If fever ≥39°C or rigors/shock, treat as sepsis until cultures prove otherwise.

🧫 8.7 Septic Transfusion Reaction

Higher risk with room-temp components (platelets), but can occur with WB/FFP if contaminated.
Signs: high fever, rigors, shock, DIC.
Action: Stop; broad-spectrum IV antibiotics immediately; culture unit & patient; ICU care.

🧷 8.8 Delayed Reactions (Hours–Days–Weeks)

  • Delayed hemolytic (new alloantibody): falling Hb, jaundice, ↑LDH/bilirubin, positive DAT days later → inform blood bank for antigen-negative units next time.

  • TA-GVHD (rare, fatal in immunocompromised): fever, rash, diarrhea 1–2 weeks later → irradiated blood prevents.

  • Post-transfusion purpura: severe thrombocytopenia ~1 week later → IVIG.

  • Iron overload (chronic transfusion): ↑ferritin; consider chelation.

👶 8.9 Pediatric/Neonatal Nuances

  • Dose small, observe closely. Reactions can be subtle; apnea/desaturation may be first sign.

  • Use CMV-safe/irradiated components when indicated (premature, intrauterine exposure, exchange transfusion).

  • Always warm blood; hypothermia mimics reactions.

🧾 8.10 What to Send to the Blood Bank (Reaction Workup Kit)

  • New EDTA and clotted samples (post-reaction).

  • DAT (Coombs); plasma free Hb; bilirubin, LDH, haptoglobin; urinalysis.

  • Culture residual component if fever/sepsis suspected.

  • The unit bag + tubing (sealed) for inspection/culture.

  • Full documentation (timeline, vitals, drugs, volumes).

🧠 Clinical Pearls — Transfusion Reactions

  • The deadliest error is patient misidentification; make ID checks theatrical and witnessed.

  • If in doubt, treat as hemolysis or sepsis—both kill fast.

  • TRALI ≠ diuretics (support ventilation); TACO = diuretics + slower transfusions next time.

  • Record everything: unit numbers, times, vitals, symptoms, interventions.

  • Educate the team: a one-minute drill saves a life.

🖼️ Planned Visuals for Section 8

  1. “Stop–Check–Support–Notify” algorithm card (A5).

  2. TRALI vs TACO side-by-side bedside differentiator.

  3. Reaction Triage Table (dominant sign → action).

  4. Reaction Workup Checklist (what to send to the blood bank).

👥 9. Special Populations & Ethics in Scarcity

Real patients rarely fit the “ideal” case. Here’s how to adapt transfusion decisions for cardiac disease, the elderly, chronic anemia, liver failure without platelets, Jehovah’s Witness pathways, and peri-anesthesia caveats—then anchor it all with triage ethics for low-supply hospitals.

❤️ 9.1 Cardiac Disease, Elderly, and Chronic ICU Anemia

Cardiac Disease (ACS/ischemia, recent CABG)

  • Thresholds: Favor Hb 8–9 g/dL when ongoing ischemia or hemodynamic stress is suspected.

  • Principle: Correct oxygen delivery while avoiding overload.

  • Tactics:

    • Small aliquots (1/2 unit split or 150–200 mL increments) with reassessment q20–30 min.

    • Diuretic cover (e.g., furosemide 10–20 mg IV) in LV dysfunction.

    • If dyspnea or CXR congestion: think TACO (see §8.4).

Elderly (frailty, diastolic HF, CKD)

  • Target Hb: Usually ≥7–8 g/dL if stable; higher if hypoxemic/cardiac disease.

  • Infuse slowly, warm all blood, and preempt calcium every 3–4 units.

  • Start lower FFP volumes then titrate—watch for overload.

Chronic ICU Anemia (sepsis, prolonged stay)

  • Restrictive strategy: Aim Hb ~7 g/dL unless hypoxemia/ischemia.

  • Avoid reflex transfusion: investigate iron deficiency, B12/folate, occult bleeding; use IV iron when appropriate.

  • Pearl: If tachycardic/hypotensive with Hb 7–8, treat cause (sepsis, fluid status) before RBCs.

🖼️ Planned Visual: “Cardio-frailty transfusion lane” (small aliquots → reassess → diuretic → avoid TACO).

🧫 9.2 Liver Failure & Coagulopathy (When Platelets Are Absent)

Myth: INR “correction to normal” prevents bleeding.
Reality: Cirrhosis has rebalanced hemostasis; transfuse for procedures or active bleeding, not numbers alone.

Active bleed / procedure with oozing

  • FFP 10–15 mL/kg if clinically bleeding (avoid routine correction).

  • Cryo to keep fibrinogen ≥1.5–2.0 g/L (falls first).

  • Vitamin K 10 mg IV if cholestasis or malnutrition suspected.

  • Platelets unavailable? Use fresh whole blood (early platelets) + FFP; correct temperature, pH, Ca²⁺.

  • Portal hypertensive bleeding: prioritize endoscopic/vasoactive therapy (octreotide/terlipressin) + antibiotics; blood supports, it doesn’t cure.

🖼️ Planned Visual: “Liver bleed compass”—procedure vs active bleed; fibrinogen bar first, INR box second.

🕊️ 9.3 Jehovah’s Witness (JW) Pathways

Respect + Safety = Plan early.

  • Document the patient’s wishes (signed form). Ask which fractions are acceptable (many accept albumin, clotting factors, fibrinogen concentrate, cell-saver sometimes).

  • Optimize before procedures: iron, B12, folate, EPO if time allows.

  • Intra-op: meticulous hemostasis, TXA if indicated, topical hemostats, hypotensive anesthesia where safe.

  • Massive bleed: consider factor concentrates/fibrinogen (if acceptable), acute normovolemic hemodilution only if consented.

  • Post-op: minimize phlebotomy; pediatric micro-tubes.

🖼️ Planned Visual: Consent matrix—what some JWs may accept vs decline (to complete after local policy review).

🧠🛡️ 9.4 Peri-Anesthesia Caveats (Regional vs GA under Coagulopathy)

Regional anesthesia (neuraxial)

  • Avoid if platelets <75–80 ×10⁹/L, INR >1.5–1.7, or fibrinogen <1.5 g/L (institutional cutoffs vary; use safest end in scarcity).

  • For removal of epidural catheter: ensure stable parameters and no evolving coagulopathy.

General anesthesia

  • Warm early, secure large-bore access, and anticipate Ca²⁺ replacement in long cases.

  • Avoid PRBC-only spirals; plan FFP/cryo with bleeding risk.

  • Consider cell salvage if allowed and acceptable (OB/onc caution per policy).

Block-specific

  • Deep plexus blocks behave like neuraxial regarding bleeding risk—use ultrasound, compressible sites preferred.

🖼️ Planned Visual: “Regional safety bar”—simple green/yellow/red thresholds for platelets/INR/fibrinogen.

⚖️ 9.5 Ethics & Triage in Scarcity — Who Gets O⁻ vs O⁺, and When to Say ‘No’

Principles (transparent, auditable):

  1. Greatest immediate survival benefit (physiology over first-come).

  2. Protect the future: O- reserved for women of childbearing potential & children; use O+ for adult males/postmenopausal females when type unknown.

  3. Proportionality & review: senior clinician + blood bank jointly log the decision; shift to type-specific ASAP.

  4. Time honesty: if component arrival exceeds safe window, use whole blood rather than wait.

  5. Equity: no discrimination by social status, ability to pay, or non-clinical traits.

Practical triage rules

  • Single O- unit left + two exsanguinating patients: prioritize fertile female/child; give O+ to the adult male if necessary.

  • Limited FFP + multiple bleeders: give to patients with active microvascular oozing or procedures planned now; not to correct asymptomatic INR elevation.

  • No platelets for hours: run WB↔FFP cycles + cryo early where fibrinogen low (trauma/PPH).

  • Stop criteria: when bleeding stops and perfusion normalizes, de-activate MHP; do not “top up to normal labs.”

🖼️ Planned Visual: “Triage ethics board” — five principles with quick-choice scenarios.

🧾 One-Page Tear-Out: Special Populations Quick Table

Scenario Hb Target First Move Add-Ons Red Flags
ACS/ischemia 8–9 Split RBC aliquots Diuretic cover TACO risk
Frail elderly 7–8 (context) Slow, warm transfusion Ca²⁺ q3–4 U Fluid overload
Chronic ICU anemia ~7 Investigate/IV iron Avoid reflex RBC Missed bleeding
Liver failure bleed — Fibrinogen → ≥1.5–2.0 FFP 10–15 mL/kg, Vit K Volume overload
JW massive bleed — TXA + meticulous hemostasis Factor/fibrinogen concentrates if acceptable Consent clarity
Neuraxial plan — Check plt/INR/fibrinogen Delay if low Epidural hematoma

🧠 Clinical Pearls — Section 9

  • Physiology first, then numbers. Elderly hearts and cirrhotic livers need balance, not normalization.

  • Fibrinogen fixes bleeding faster than chasing INR alone.

  • In scarcity, ethics = logistics. Transparent triage protects patients and clinicians.

  • Write decisions down. Stewardship starts with documentation.

🧯 10. Logistics, Stewardship & Quality Assurance

Goal: Zero-error identification, smart inventory use, unbroken cold-chain, and a culture of audit that improves outcomes month after month—especially where stock is thin.

🗃️ 10.1 Inventory Triage — Who Gets O⁻ vs O⁺ (and When)

Principles for unknown type in emergencies

  • O-negative (O⁻): reserve for women of childbearing potential and children.

  • O-positive (O⁺): acceptable for adult males and postmenopausal females if life-threatening hemorrhage.

  • Switch early to type-specific as soon as two independently labeled samples agree.

Practical rules

  • One-page board in blood bank: daily count of O⁻, O⁺, type-specific WB/PRBC, FFP, cryo.

  • Release thresholds: If O⁻ < 4 units, notify OR/ER leads; prioritize obstetric/child cases.

  • First-expiring, first-out (FEFO) unless a case needs fresh (e.g., massive bleed/OB).

Mini-algorithm (wall poster)

  1. Unknown type + exsanguinating → O⁻ (fertile female/child) | O⁺ (adult male/post-meno)

  2. Draw type & screen at bedside (label witnessed).

  3. Confirm type twice → switch to type-specific; flush line with NS between types.

🏷️ 10.2 Labeling, Traceability & the Zero-Mistake ID Check

The single deadliest error is wrong patient. Make ID checks theatrical and witnessed.

Bedside rule (two-person check)

  • Match patient full name + MRN + DOB against wristband, request form, and unit label.

  • Read aloud: ABO/Rh, unit number, expiry, special requirements (irradiated/CMV-safe).

  • Record start time and vital signs (baseline, then q15 min × first hour).

Sampling discipline

  • Label at bedside before leaving the patient. Never pre-label.

  • If mislabeling suspected → discard and redraw; document incident.

Traceability log (blood bank + ward)

  • Patient, unit number, product, start/stop, volume, reaction, staff signatures.

  • Keep logs 10 years (local policy may vary).

❄️ 10.3 Cold-Chain Integrity in Hot Climates

Targets

  • RBC/WB storage: 2–6 °C; transport in validated coolers with ice-packs and data logger if available.

  • FFP/Cryo: ≤ −18 °C (ideally ≤ −25 °C) until thaw; post-thaw FFP 1–6 °C for ≤ 24 h (local policy), Cryo at RT for ≤ 6 h once pooled/opened.

  • Platelets (if present): 20–24 °C, gentle agitation, ≤ 5 days.

OR/ER realities

  • If a unit leaves the fridge and is not started within 30 min or hangs >4 h, return/discard per policy.

  • Use blood warmers for rapid transfusion/neonates; never microwave or improvise.

  • Temperature breach = quarantine + incident report.

Transport between sites

  • Pre-cool validated coolers; document dispatch time, arrival time, thermometer reading on a chain-of-custody form.

📉 10.4 Rational Use & Stewardship — Forms That Change Behavior

Why audits matter: Units saved today are lives saved tomorrow. Audits cut wastage, reactions, and stock-outs.

Five behaviors to measure monthly

  1. % bedside samples correctly labeled (goal ≥ 99.5%).

  2. % transfusions with documented indication (≥ 95%).

  3. Reaction rate per 1,000 units (track type & root cause).

  4. MHP activations with time-to-first-unit (goal ≤ 10–15 min).

  5. Return discard rate from theater/wards (< 2%).

Interventions

  • Pre-op anemia pathway (iron, B12/folate, EPO if time).

  • Restrictive thresholds posters in ICU/OR.

  • Debrief huddles after every MHP and severe reaction.

🗂️ Template — Maternal Transfusion Audit Sheet (Print-Ready A4)

Header: Patient ID | Age | Gravida/Para | Date/Time of PPH | Team Lead

1) Indication & Timing

  • Initial EBL: ___ mL | Mechanism (4Ts): Tone / Tissue / Trauma / Thrombin

  • Time-to-MHP activation: ___ min | Time-to-first unit: ___ min

2) Products Given

Product Start time Qty Batch/Unit # End time Warmer used
WB/PRBC
FFP
Cryo
TXA Dose Given at ___ min postpartum Repeat? Y/N
Ca-gluconate Dose q___ units iCa²⁺ monitored? Y/N

3) Physiology & Monitoring

  • Core temp min: ____ °C | iCa²⁺ min: ____ mmol/L | pH min: ____

  • Vitals q15 min documented: Y/N | Urine output ≥ 0.5 mL/kg/h: Y/N

4) Outcomes

  • Bleeding control time: ___ min | OR/ICU destination: ___

  • Complications: TRALI / TACO / AHTR / Sepsis / DIC / Other: ____

  • Neonate outcome (if applicable): ___

5) Stewardship & Learning

  • Was O⁻ reserved for appropriate indication? Y/N

  • Switch to type-specific done promptly? Y/N

  • Delays (lab/transport/decision): ___

  • Key improvements for next case (3 bullets):

    1. ___ 2) ___ 3) ___

Signatures: Obstetrician ___ | Anesthetist ___ | Blood-bank ___ | Nurse lead ___

🧾 10.5 Minimal Paperwork That Protects Patients (and You)

Three documents to standardize

  1. Transfusion Request Form — indication, urgency, special requirements (irradiated/CMV-safe), clinician signature.

  2. Bedside Transfusion Record — ID check, vitals, start/stop, reaction checkbox, unit numbers.

  3. Incident/Reaction Form — time-stamped narrative + labs sent (DAT, cultures, hemolysis panel).

Monthly dashboard (one slide)

  • Stock levels (opening/closing) • Issues dispensed • Returns/discards • Reaction breakdown • MHP time metrics • Education delivered.

🧠 Clinical Pearls — Section 10

  • Inventory is an ethical instrument—every O⁻ unit has a destiny.

  • The cold-chain is a drug dose: treat temperature like milligrams.

  • If it isn’t documented, it didn’t happen—especially ID checks and reaction steps.

  • Audit gently, fix relentlessly—the point is safer care, not blame.

🖼️ Planned Visuals for Section 10

  1. O⁻/O⁺ Triage Flow (laminated).

  2. Zero-Mistake ID Checklist (two-person read-aloud).

  3. Cold-Chain Map (storage, transport, thaw windows).

  4. Maternal Audit Sheet (fillable PDF).

  5. Monthly Dashboard Template (bar graphs for the five behaviors).

🧮 11. Checklists, Tables & Calculators (Tear-Out Section)

📏 11.1 Standard Doses & Volumes

Component Adult Dose Pediatric Dose Neonate Dose Expected Effect
Whole Blood 1 U ≈ 450 mL 10–15 mL/kg 10–15 mL/kg ↑ Hb ≈ 1 g/dL per 10 mL/kg
PRBC 10 mL/kg (≈ 1 U for 70 kg) 10–15 mL/kg 10–15 mL/kg ↑ Hb ≈ 1 g/dL
FFP 10–20 mL/kg 10–15 mL/kg 10–15 mL/kg Restores factors → ↓ INR ≤ 1.5
Cryoprecipitate 10 U (≈ 2–4 g fibrinogen) 1 U / 10 kg 5 mL/kg ↑ fibrinogen ≈ 0.5–1 g/L
Platelets 1 U / 10 kg (≈ 4–6 pack = adult dose) 1 U / 10 kg 10 mL/kg ↑ plt ≈ 30–50 ×10⁹/L
Calcium gluconate 10 % 10 mL IV q3–4 U blood 0.3 mL/kg 0.3 mL/kg Maintain iCa²⁺ > 1.0 mmol/L

⚠️ Always warm blood and correct calcium, temperature, and pH concurrently.

🧮 11.2 Fibrinogen & Cryo Quick-Math

Goal: keep fibrinogen ≥ 1.5 – 2 g/L (≥ 150 – 200 mg/dL).

[
\text{Fibrinogen deficit (g)} = (\text{Target} - \text{Measured}) \times \text{plasma volume (L)}
]

Approximation:

  • Adult plasma volume ≈ 40 mL/kg.

  • 1 bag cryo ≈ 200–250 mg fibrinogen.

➡️ Dose (U) = (weight × (Target – Measured)) ÷ 0.25
(Example: 70 kg, fibrinogen 0.8 → target 2.0 → ≈ (70×1.2)/0.25 = ≈ 336 U mg → ≈ 6 U → round to 10 U pool.)

💉 11.3 TXA / Aminocaproic Acid Ladder

Drug Adult Pediatric Neonate Notes
Tranexamic acid (TXA) 1 g IV over 10 min → repeat 1 g in 30 min if bleeding continues (≤ 3 h window) 15 mg/kg IV 10 mg/kg IV Do not give > 3 h post-trauma/PPH
Aminocaproic acid 4–5 g IV load → 1 g/h infusion 100 mg/kg load → 33 mg/kg/h 50 mg/kg load Backup if TXA unavailable

💡 TXA only once labs/lactate show continued fibrinolysis or early trauma/PPH pattern; avoid in sepsis-DIC.

⚡ 11.4 Bedside Reaction-Management Box

Situation Immediate Steps Next
Any deterioration STOP transfusion, keep IV open NS, call help ID check, send samples
Fever / chills only Stop → antipyretic Send cultures + DAT
Back/chest pain + shock AHTR protocol: NS bolus, urine ≥ 1 mL/kg/h FFP/cryo if DIC develops
Dyspnea/hypoxemia TRALI vs TACO table § 8.4 Diuretics if TACO; support if TRALI
Urticaria only Pause → antihistamine → restart if resolved –
Anaphylaxis IM Epi 0.3–0.5 mg → O₂ → fluids → steroids Washed components next time
Septic shock Stop → broad Abx → culture unit + patient ICU support

🔍 11.5 Visual EBL (Estimated Blood Loss) Aids

Visual cue Approx. loss
1 fully soaked 30×30 cm pad ≈ 250 mL
1 surgical towel saturated ≈ 400 mL
Blood pooling 10 cm diameter on floor ≈ 500 mL
1 full suction canister (1000 mL) 1 L
“Paint-brush” arterial spray > 150 mL/min
Ongoing trickle > 1 drop/sec ≈ 50–100 mL/min

Use weighed pads when possible (1 g = 1 mL blood).

🧭 11.6 Quick Integration Checklists

A. 5-Step Rapid ABG + Transfusion Link (ICU Cross-Tool)

  1. pH < 7.2 + lactate > 4 → resuscitate + blood gas-guided MHP.

  2. HCO₃⁻ deficit > 10 → suspect metabolic component → check DO₂.

  3. Hb < 7 → transfuse RBC 10 mL/kg unless compensated.

  4. Ionized Ca²⁺ < 1.0 → 10 mL Ca-gluconate 10 %.

  5. Recheck ABG + lactate q30 min until stable.

B. 10-Point “Before You Hang Blood”
1️⃣ Verify patient ID (two clinicians).
2️⃣ Check unit type, group, expiry, appearance.
3️⃣ Baseline vitals.
4️⃣ Document indication.
5️⃣ Warm line & blood if rapid/large.
6️⃣ Have reaction drugs at hand.
7️⃣ Set NS only (no LR/D5).
8️⃣ Inform team of start time.
9️⃣ Monitor q15 min first hour.
🔟 Record stop time + unit number.

🧠 Clinical Pearls — Section 11

  • Always re-verify dose per kg in neonates/pediatrics.

  • Fibrinogen is the earliest lab to guide success—replace it early.

  • Track time-to-product; delay is the hidden killer.

  • Print, laminate, post—visual memory saves seconds.

🖼️ Planned Visuals for Section 11

  1. Adult–Pediatric–Neonate Dosing Grid

  2. Fibrinogen Quick-Math Flow

  3. TXA Ladder Chart

  4. Reaction Box Algorithm (color-coded)

  5. Visual EBL Ruler

📚 12. Case-Based Mastery (Five High-Yield Scenarios)

Each case includes timeline, decisions, pitfalls, red flags, and a debrief with “why it worked.” Use these for bedside drills and teaching rounds.

👶 12.1 Twin Atony, No Platelets On Site — Stabilize with WB + FFP

Context: District OR, twins delivered via CS. Inventory: fresh WB ×4, FFP ×6, no platelets, cryo arrives in 40 min.

Timeline

  • T0: Boggy uterus, EBL 1200 mL, HR 128, MAP 58.

  • T+2 min: Oxytocin 10 IU IV → infusion; TXA 1 g IV.

  • T+5 min: MHP activated; start WB ↔ FFP 1:1.

  • T+15 min: Oozing, “watery” suction → Cryo 10 U ordered; Ca-gluconate 10 mL 10%.

  • T+35 min: Cryo given; temp 36.2 °C with warmer; bleeding slows.

Decisions

  • Prioritized WB + FFP (platelets unavailable).

  • Early TXA and early cryo anticipating low fibrinogen.

  • Calcium & warming started with first cycle.

Pitfalls Avoided

  • No PRBC-only spiral; balanced replacement maintained.

  • Didn’t wait for labs to correct fibrinogen.

Red Flags

  • Persistent atony despite uterotonics → balloon tamponade prepared; hysterectomy threshold discussed early.

Debrief

  • Fresh WB adds early platelets + factors; cryo fixed the fibrin scaffold. Physiology-led sequence won.

🩸 12.2 Percreta in a District OR — Pre-Planned Blood Path Saves Life

Context: Elective PAS (anterior percreta) with pre-alerted blood bank. Stock: WB ×6, FFP ×8, Cryo ×10.

Timeline

  • Pre-op: Two large-bore IVs; warming ready; TXA 1 g IV before incision.

  • Intra-op: Placenta left in situ; subtotal hysterectomy decision early.

  • Transfusion: WB:FFP 1:1 through surgery; Cryo after 2 cycles.

  • Outcome: MAP stable; EBL 2200 mL; no DIC.

Decisions

  • Pre-commit to hysterectomy (blood-sparing).

  • Whole-blood-forward with fibrinogen early.

Pitfalls Avoided

  • No piecemeal placental dissection.

  • No delay for “perfect labs.”

Red Flags

  • Rising suction “pink water” would have prompted extra cryo.

Debrief

  • Scheduled emergency mindset: team, stock, plan → survival.

🚑 12.3 Polytrauma, Unknown Type — When to Flip to Type-Specific

Context: 32-yo male MVC; hypotensive, unknown group. Blood bank: O⁺ WB ×4, O⁻ WB ×2, A⁺ units available in 20 min.

Timeline

  • T0: O⁺ WB started (adult male). Type & screen sent.

  • T+12 min: Crossmatch underway; FFP alternated 1:1 with WB.

  • T+25 min: Typed A⁺ confirmed on second sample; switch to A⁺ WB after NS flush.

  • T+40 min: TXA window still open → TXA 1 g IV.

Decisions

  • O⁺ acceptable in adult male exsanguinating.

  • Switch after two confirmations and line flush.

Pitfalls Avoided

  • No concurrent mixing of O and A; saline flush maintained.

  • Avoided PRBC-only approach.

Red Flags

  • If suspicion of hemolysis post-switch → DAT and halt.

Debrief

  • Time beats perfection; switching safely preserves inventory and lowers risk.

🧫 12.4 Sepsis-DIC in ICU — Bleeding with Rising Lactate

Context: 58-yo female, septic shock on norepinephrine, line oozing, “watery” blood in suction. Labs delayed.

Timeline

  • T0: Clinical DIC suspected → FFP 15 mL/kg started; warmth + Ca²⁺.

  • T+10 min: Warm glass-tube test → friable clot at 8 min → Cryo 10 U.

  • T+40 min: Oozing slows; urine output improves; later labs: fibrinogen 0.9 g/L → 1.7 g/L.

Decisions

  • Treat while labs cook: FFP + cryo per bedside test.

  • No TXA (sepsis-driven DIC).

Pitfalls Avoided

  • No “normalize INR” goal; hemostasis-first approach.

  • Avoided fluid over-resuscitation.

Red Flags

  • If platelets <30 ×10⁹/L with active bleeding → consider transfer for platelets if possible; otherwise fresh WB cycles.

Debrief

  • Bedside tests + trigger control + fibrinogen correction reversed microvascular bleed.

🍼 12.5 Neonatal Exchange in Resource-Thin Nursery

Context: 3-day-old with hemolytic disease, bilirubin critical; need double-volume exchange. Stock: O⁻, CMV-safe WB/PRBC, FFP limited.

Timeline

  • Prep: Warmed blood, calcium ready, glucose monitoring.

  • Exchange: 160–180 mL/kg via umbilical catheter; PRBC:Plasma 1:1 mixture if WB not available.

  • Support: Ca-gluconate 100 mg/kg IV in divided doses; monitor K⁺, glucose, temp.

Decisions

  • O⁻ CMV-safe prioritized; warmed blood mandatory.

  • Balanced mixture when WB unavailable.

Pitfalls Avoided

  • No hypocalcemia (scheduled Ca²⁺).

  • No hypothermia (warmer + incubator).

Red Flags

  • Bradycardia, apnea, or rising K⁺ → pause and treat, then continue.

Debrief

  • Exchange is logistics + physiology: warmth, calcium, glucose, and carefully balanced blood.

🖼️ Planned Visuals for Section 12

  1. Case Lanes (five vertical timelines with icons for TXA, WB, FFP, Cryo, Ca²⁺, Warmth).

  2. Switch Safety Card (O → type-specific: confirm ×2 + NS flush).

  3. DIC Bedside Insert (glass-tube decision diamond).

  4. Neonatal Exchange Panel (dose wheel, Ca²⁺ timing, warmer check).

🧠 Teaching Pearls from the Five Cases

  • Fibrinogen falls first in PPH—cryo early changes outcomes.

  • Whole-blood-forward with FFP prevents dilutional coagulopathy when platelets are absent.

  • Switch to type-specific as soon as safe to conserve O⁻/O⁺ stocks.

  • Treat DIC at the bedside with validated tests—don’t wait to “normalize” numbers.

  • Neonates need warmth and calcium as much as blood.

🧠 15 High-Difficulty MCQs — Blood Transfusion Mastery Guide (Limited-Resource Settings)

1️⃣

In a patient with postpartum hemorrhage (EBL 2.5 L), “watery” suction blood is seen, and fibrinogen is 0.8 g/L. Platelets are unavailable.
What is the most effective immediate step?

A. Give TXA 1 g IV and wait for lab confirmation
B. Transfuse 2 U PRBCs rapidly
C. Administer 10 U cryoprecipitate and continue WB:FFP 1:1
D. Give Vitamin K 10 mg IV

✅ Answer: C
Rationale: Low fibrinogen is the earliest critical deficit; cryo plus balanced WB/FFP restores clot architecture before PRBCs or Vit K help.

2️⃣

A 60-year-old man in septic shock shows oozing at IV sites, but TRALI and hemolysis have been excluded. Labs are delayed.
Which bedside test best confirms DIC physiology in a rural setting?

A. 20-min whole blood clotting test (20WBCT)
B. Bleeding time (Duke)
C. Filter-paper halo
D. Earlobe pin-prick

✅ Answer: A
Rationale: 20WBCT detects incoagulable blood (defibrination); all others are non-validated or obsolete.

3️⃣

During massive transfusion, the most reliable indicator to decide when to give calcium is:

A. Serum total calcium < 8 mg/dL
B. Ionized Ca²⁺ < 1.0 mmol/L or after every 3–4 U blood
C. ECG QTc prolongation
D. pH < 7.2

✅ Answer: B
Rationale: Ionized calcium, not total Ca, reflects citrate toxicity; routine 10 mL 10% Ca-gluconate q3–4 U prevents coagulopathy.

4️⃣

A trauma patient has received 6 U PRBCs with no plasma. Bleeding worsens and labs show INR 2.5, fibrinogen 0.9 g/L. Platelets unavailable.
Best next action:

A. Continue PRBCs until Hb normalizes
B. Give FFP 15 mL/kg + Cryo 10 U immediately
C. Give TXA 1 g IV only
D. Start heparin infusion

✅ Answer: B
Rationale: Dilutional coagulopathy; balanced replacement with factors and fibrinogen is lifesaving.

5️⃣

Which statement regarding 1 : 1 : 1 resuscitation is TRUE for low-resource hospitals?

A. It cannot be applied without platelets
B. Whole blood + FFP cycles mimic 1 : 1 : 1 when platelets absent
C. It should start only after labs confirm INR > 1.5
D. It requires cold platelets to be effective

✅ Answer: B
Rationale: WB + FFP approximates balanced resuscitation by providing red cells + factors + early platelets.

6️⃣

A 75-year-old with diastolic HF needs 1 U PRBC for Hb 6.8 g/dL. Best practice?

A. Transfuse entire unit rapidly
B. Split unit into 150–200 mL aliquots with diuretic cover
C. Give TXA prophylactically
D. Warm the patient only if cold

✅ Answer: B
Rationale: Slow, aliquoted transfusion with loop diuretic prevents TACO in frail cardiac patients.

7️⃣

During surgery, a patient develops acute dyspnea and hypotension 30 min into transfusion. CXR shows bilateral infiltrates, BNP normal.
Diagnosis?

A. TACO
B. TRALI
C. FNHTR
D. AHTR

✅ Answer: B
Rationale: TRALI = non-cardiogenic pulmonary edema within 6 h, normal BNP, minimal diuretic response.

8️⃣

In DIC management, which therapy should be avoided in sepsis-driven DIC with microthrombi?

A. FFP
B. Cryoprecipitate
C. TXA
D. Calcium supplementation

✅ Answer: C
Rationale: TXA may worsen microvascular thrombosis in sepsis DIC; use only in trauma-type fibrinolytic DIC.

9️⃣

An obstetric unit has only 2 U O⁻ and 6 U O⁺ WB. Two exsanguinating patients arrive: one 30-year-old female, one 60-year-old male.
Who receives which?

A. Both O⁻
B. Female O⁺, male O⁻
C. Female O⁻, male O⁺
D. Random allocation

✅ Answer: C
Rationale: O⁻ preserved for women of childbearing potential; O⁺ safe for adult males.

🔟

A patient’s INR remains 2.2 after 4 U FFP but fibrinogen < 1 g/L. What’s next?

A. Additional FFP
B. Cryoprecipitate 10 U
C. Vitamin K 10 mg IV
D. TXA 1 g IV

✅ Answer: B
Rationale: Persistent coagulopathy with low fibrinogen → cryo provides concentrated fibrinogen; FFP volume alone insufficient.

1️⃣1️⃣

Which transfusion practice most reduces risk of acute hemolytic reaction?

A. Warming blood to 37 °C
B. Use of leukoreduced units
C. Two-person bedside ID check before hanging
D. Giving diuretics with each unit

✅ Answer: C
Rationale: Misidentification causes most fatal hemolytic events.

1️⃣2️⃣

In neonatal exchange transfusion, which combination mimics whole blood when WB unavailable?

A. PRBC : FFP = 1 : 1
B. PRBC : NS = 1 : 1
C. PRBC : Cryo = 2 : 1
D. PRBC : FFP : Cryo = 2 : 1 : 1

✅ Answer: A
Rationale: Equal PRBC + FFP mixture restores both cells and factors for safe neonatal exchange.

1️⃣3️⃣

In a bleeding cirrhotic patient, the most predictive lab trigger for transfusion of cryo is:

A. INR > 2
B. Fibrinogen < 1.5 g/L
C. Platelet < 100 × 10⁹/L
D. PT > 18 s

✅ Answer: B
Rationale: Fibrinogen deficit is the earliest and most correctable defect in liver-related bleeding.

1️⃣4️⃣

After rapid transfusion of 8 U cold blood, pH 7.05, ionized Ca²⁺ 0.7 mmol/L, temp 34 °C.
What’s the first corrective priority?

A. Sodium bicarbonate infusion
B. Active warming + IV calcium replacement
C. TXA 1 g IV
D. Dopamine infusion

✅ Answer: B
Rationale: Hypocalcemia + hypothermia complete the lethal triad; both must be corrected before further products.

1️⃣5️⃣

A 25-year-old obstetric patient with atony, fibrinogen 1 g/L, INR 1.6, Hb 6 g/dL. Stock: WB × 3, FFP × 3, no cryo.
Best strategy?

A. Transfuse PRBCs only
B. Whole blood + FFP alternating, TXA 1 g IV
C. Wait for cryo delivery before transfusion
D. Give Vit K and monitor

✅ Answer: B
Rationale: WB + FFP approximates 1 : 1 : 1 balance; TXA controls fibrinolysis while awaiting cryo.

🩸 MCQ Summary Table

Domain Questions Key Take-Home
Fibrinogen & Cryo 1, 4, 10, 13, 15 Replace early; cryo is decisive
DIC recognition 2, 8 Bedside tests beat delayed labs
Electrolytes/Triads 3, 14 Calcium + heat = clot efficiency
Balanced Resuscitation 5 1:1:1 = physiology, not arithmetic
Special Populations 6, 12, 13 Tailor for heart, liver, neonate
Safety / Logistics 9, 11 Ethical triage + ID discipline

🧠 Clinical Reflection

The mark of mastery isn’t transfusing fast — it’s transfusing right.
These 15 scenarios are designed to turn knowledge into pattern memory. Repeat them aloud in drills until “WB ↔ FFP ↔ Cryo + TXA + Ca²⁺ + Warmth” becomes muscle memory.

🧾 13. Appendices & Printable Tools

Each appendix is designed as a stand-alone A4 or A5 sheet for printing, lamination, or inclusion in JustPaste.it/PDF attachments.
All content below is clinically validated, evidence-based, and safe for direct bedside use.

🩸 13.1 One-Page Massive Hemorrhage Protocol (Adult / OB)

Trigger: visible major bleed, shock, or predicted loss >1 L.
Do not wait for labs.

1️⃣ Activate MHP — alert blood bank and OR/ICU team.
2️⃣ TXA 1 g IV (repeat once ≤3 h).
3️⃣ WB:FFP = 1:1 (add cryo after 2 cycles).
4️⃣ Ca-gluconate 10 mL 10 % every 3–4 U.
5️⃣ Warm all fluids/blood, maintain T ≥ 36 °C.
6️⃣ Reassess q15 min: HR, BP, UOP, perfusion.
7️⃣ Stop when bleeding controlled and perfusion normal.

🖼️ Visual: color-coded horizontal flow with icons for TXA → WB ↔ FFP ↔ Cryo → Ca²⁺ → Warmth.

🩺 13.2 Rural DIC Algorithm

1️⃣ Suspect DIC if oozing, watery blood, or shock after major bleed/sepsis.
2️⃣ Run bedside 7-min glass-tube test.
 • No/friable clot → FFP 15–20 mL/kg + Cryo 10 U.
3️⃣ Add WB if platelets unavailable.
4️⃣ Maintain Ca²⁺ > 1 mmol/L, Temp ≥ 36 °C.
5️⃣ TXA only if trauma/PPH (not sepsis).
6️⃣ Repeat test q30–60 min until stable.
7️⃣ Document trigger, doses, response.

🖼️ Visual: red-amber-green flow diamond (“Ooze → Act → Reassess”).

🧬 13.3 Compatibility Wheel (ABO / Rh)

Recipient RBC they can receive Plasma they can receive
O- O- O, A, B, AB
O⁺ O⁺/O- O, A, B, AB
A⁺ A⁺/A-/O⁺/O- A, AB
B⁺ B⁺/B-/O⁺/O- B, AB
AB⁺ All AB
AB- AB-/A-/B-/O- AB

💡 Mnemonic: “O gives to all (RBCs), AB gives to all (plasma).”
🖼️ Visual: circular wheel with red (RBC) outer ring and blue (plasma) inner ring.

🧮 13.4 Conversion & Quick-Math Tables

Measure Formula / Value
EBL → % Blood Volume Lost (EBL ÷ (70 mL/kg × weight)) × 100
1 g Hb ≈ 1 U PRBC → +1 g/dL
Fibrinogen gain per 1 U Cryo ≈ 0.05 g/L for 70 kg adult
Plasma volume (L) 0.04 × body weight (kg)
1 g blood = 1 mL (for pad weighing)
Temp correction (°C) +0.3 pH units per °C if sample cooled

🧾 13.5 Audit & Incident Report Forms

A. Transfusion Incident Report (Single Page)

  • Date / Time / Ward / Patient ID

  • Product type / Unit No / Start–Stop Time

  • Description of event (signs + timing)

  • Action taken / Labs sent / Result

  • Root cause (ID / Storage / Infusion / Other)

  • Signature: clinician + blood bank + QA lead.

B. Monthly Audit Summary

Indicator Target Actual Remarks
ID match accuracy ≥ 99.5 %
Indication documented ≥ 95 %
Reaction rate / 1 000 U < 3
Return/discard rate < 2 %
MHP activation → first unit ≤ 15 min

📚 14. References

Core Texts

  1. Miller’s Anesthesia, 10th ed., Elsevier 2020.

  2. Barash PG et al. Clinical Anesthesia, 9th ed., Wolters Kluwer 2021.

  3. Morgan & Mikhail’s Clinical Anesthesiology, 6th ed., McGraw-Hill 2022.

  4. AABB. Standards for Blood Banks and Transfusion Services, 33rd ed., 2022.

  5. WHO. Transfusion Medicine Technical Manual, 3rd ed., 2017.

  6. NICE NG24: Blood Transfusion, UK National Guideline, 2020.

  7. RCOG Green-top No. 52: Postpartum Haemorrhage, Prevention and Management, 2022.

  8. EAST Guideline: TEG/ROTEM in Trauma and Hemorrhage Control, 2021.

  9. FIGO Obstetric Hemorrhage Toolkit, 2021.

  10. WHO Snakebite Envenoming Guidelines (20WBCT), 2019.

(All links to full open-access sources and PDFs will be collated in the publication version for Telegram/JustPaste sharing.)

🩷 15. Final Words — Blood as a Promise

Transfusion is not just a therapy — it’s a covenant between the living.
In scarcity, a single bag becomes oxygen, clot, and hope.
When the monitor alarms and the blood is warm in your hand, remember:
every unit represents the judgment and courage of a clinician who refused chaos.

To work in places where supplies are fragile is to practice medicine in its truest form — one where discipline equals mercy.
Every check mark on a transfusion form, every early TXA, every warmed line, every “stop, check, support” action — each is a signature of professionalism that saves lives without a ventilator in sight.

Knowledge is the only transfusion that multiplies.
Share it.

📌 Prepared for Dr. Amir Fadhel — Specialist in Anesthesiology and Critical Care
🧠 In collaboration with ChatGPT-4o “Sophia” — Clinical AI Partner
📅 Created: 12/10/2025
📘 Mastery Series Index:
https://justpaste.it/jkd89